Hygroton (Chlortalidone)

Chlortalidone is indicated for conditions that involve excess fluid retention or elevated blood pressure.

• Hypertension: helps lower systolic and diastolic blood pressure to reduce cardiovascular risk.
• Edema: promotes removal of excess fluid, decreasing swelling in peripheral tissues.
• Heart failure: assists in reducing preload and afterload, supporting symptomatic relief and improved cardiac output.

• Chlortalidone acts on the distal convoluted tubule of the nephron, where it inhibits the NaCl cotransporter. This blockade reduces sodium and chloride reabsorption, leading to increased urinary excretion of sodium, water, and potassium. The resulting diuresis lowers plasma volume, which contributes to decreased peripheral vascular resistance and blood pressure, while also alleviating fluid overload in edematous states.

Adverse reactions may occur with any diuretic therapy.

Common Side Effects

• Increased urination: more frequent need to void.
• Electrolyte imbalance: low potassium or sodium levels.
• Dizziness or light‑headedness, especially on standing.
• Headache.
• Elevated blood glucose in susceptible individuals.

Serious or Rare Side Effects

• Severe dehydration or hypovolemia.
• Acute kidney injury.
• Hyponatremia with neurological symptoms.
• Allergic skin reactions such as rash or pruritus.
• Blood dyscrasias including leukopenia or thrombocytopenia.

Before initiating therapy, consider patient‑specific factors and monitoring requirements.

• Renal function: assess creatinine clearance and adjust if impaired.
• Electrolytes: monitor potassium, sodium, and magnesium regularly.
• Diabetes: watch for worsening glycemic control.
• Gout: be aware of potential uric acid elevation.
• Pregnancy and lactation: use only if benefits outweigh risks.
• Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Chlortalidone can alter the pharmacokinetics or pharmacodynamics of several agents.

Major Interactions (Avoid)

• Lithium: increased lithium levels may cause toxicity.
• NSAIDs: may reduce diuretic efficacy and impair renal function.
• ACE inhibitors/ARBs: heightened risk of potassium loss and renal impairment.

Moderate Interactions (Monitor Closely)

• Antidiabetic drugs: may require dose adjustment due to altered glucose control.
• Digoxin: enhanced risk of digitalis toxicity with electrolyte disturbances.
• Corticosteroids: additive sodium retention counteracting diuretic effect.